EnVVeno Financial Statements From 2010 to 2026

NVNO Stock  USD 11.93  1.92  19.18%   
EnVVeno Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing EnVVeno Medical's valuation are provided below:
Market Capitalization
6.6 M
Earnings Share
(37.80)
We have found one hundred twenty available fundamental signals for enVVeno Medical Corp, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to verify EnVVeno Medical's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 31st of January 2026, Enterprise Value is likely to grow to about 979.7 K, while Market Cap is likely to drop about 970.3 K.

EnVVeno Medical Total Revenue

0.0

Check EnVVeno Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EnVVeno Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 351.6 K, Interest Expense of 224.9 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 7.61, Dividend Yield of 0.0 or PTB Ratio of 0.0337. EnVVeno financial statements analysis is a perfect complement when working with EnVVeno Medical Valuation or Volatility modules.
  
Build AI portfolio with EnVVeno Stock
Check out the analysis of EnVVeno Medical Correlation against competitors.

EnVVeno Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets54.3 M51.7 M19.5 M
Slightly volatile
Short and Long Term Debt Total1.5 M1.2 M1.3 M
Pretty Stable
Other Current Liabilities308.7 K324.9 K1.1 M
Slightly volatile
Total Current Liabilities2.3 M1.9 MM
Slightly volatile
Property Plant And Equipment NetM1.4 M755.3 K
Slightly volatile
Accounts Payable701.3 K905.4 K826.9 K
Pretty Stable
Cash1.9 MM4.9 M
Pretty Stable
Non Current Assets Total1.7 M1.4 M1.5 M
Slightly volatile
Non Currrent Assets Other26.5 K27.9 K93.4 K
Very volatile
Cash And Short Term Investments52.1 M49.6 M17.7 M
Slightly volatile
Common Stock Shares Outstanding16.9 K16.1 K4.5 K
Slightly volatile
Liabilities And Stockholders Equity54.3 M51.7 M19.5 M
Slightly volatile
Other Current Assets701.6 K668.1 K354 K
Slightly volatile
Other Stockholder Equity234.3 M223.1 M86 M
Slightly volatile
Total Liabilities2.7 M2.5 M3.4 M
Slightly volatile
Total Current Assets52.8 M50.3 M18 M
Slightly volatile
Short Term Debt749.8 K655.2 K940.4 K
Slightly volatile
Intangible Assets781.6 K599.8 K833.7 K
Slightly volatile
Common Stock83.985.5104
Slightly volatile
Non Current Liabilities TotalM805 K692.1 K
Slightly volatile
Net Receivables27.4 K28.8 K100.8 K
Slightly volatile
Deferred Long Term Liabilities704.5 K792.6 K865.1 K
Slightly volatile
Short and Long Term Debt267.4 K281.4 K1.4 M
Slightly volatile
Property Plant Equipment968.9 K599.1 K474.2 K
Slightly volatile
Capital Lease Obligations1.4 M1.2 M1.1 M
Slightly volatile
Property Plant And Equipment Gross2.7 M2.8 MM
Slightly volatile
Capital Surpluse116.2 M130.7 M142.7 M
Slightly volatile
Non Current Liabilities Other1.1 M1.3 M1.4 M
Slightly volatile

EnVVeno Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization351.6 K607.2 K294.8 K
Slightly volatile
Interest Expense224.9 K236.7 K619.3 K
Very volatile
Other Operating Expenses28.8 M27.4 M11.2 M
Slightly volatile
Total Operating Expenses28.1 M26.8 M10.9 M
Slightly volatile
Selling General Administrative9.8 M13.3 M7.8 M
Slightly volatile
Research Development14.8 M14.1 M4.9 M
Slightly volatile
Reconciled Depreciation426.4 K607.2 K300.5 K
Slightly volatile
Interest Income469.7 K447.4 K128 K
Slightly volatile
Non Operating Income Net Other81.6 K91.8 K100.2 K
Slightly volatile

EnVVeno Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow7.9 M4.2 M5.3 M
Slightly volatile
Depreciation338.2 K607.2 K254.6 K
Slightly volatile
Capital Expenditures40.4 K42.5 K92.9 K
Pretty Stable
End Period Cash Flow1.9 MMM
Pretty Stable
Stock Based Compensation3.7 M4.8 M2.8 M
Slightly volatile
Change To Netincome10.9 M10.4 M3.7 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.617.255.4253
Slightly volatile
Days Sales Outstanding68.1572.0574.0341
Slightly volatile
Average PayablesM694.6 K828.4 K
Pretty Stable
Stock Based Compensation To Revenue28.4927.1315.4326
Slightly volatile
Capex To Depreciation0.07660.08060.3836
Pretty Stable
Inventory Turnover8.469.5210.3897
Slightly volatile
Days Of Inventory On Hand27.6131.0633.9022
Slightly volatile
Payables Turnover0.580.470.5624
Pretty Stable
Research And Ddevelopement To Revenue66.7363.5533.7002
Slightly volatile
Capex To Revenue11.0110.485.4363
Slightly volatile
Cash Per Share3.3 K2.8 K3.1 K
Slightly volatile
Days Payables Outstanding870800899
Slightly volatile
Intangibles To Total Assets0.20.220.3702
Slightly volatile
Current Ratio19.7318.799.4801
Slightly volatile
Receivables Turnover5.85.245.3741
Slightly volatile
Capex Per Share2.893.04122
Very volatile
Average Receivables36.7 K38.6 K73.5 K
Slightly volatile
Revenue Per Share66.2869.77759
Slightly volatile
Interest Debt Per Share83.0787.444.5 K
Slightly volatile
Debt To Assets0.02590.02720.3695
Slightly volatile
Operating Cycle80.872.0588.9887
Slightly volatile
Days Of Payables Outstanding870800899
Slightly volatile
Ebt Per Ebit1.211.051.0952
Pretty Stable
Quick Ratio19.7318.799.4775
Slightly volatile
Net Income Per E B T1.321.211.1788
Slightly volatile
Cash Ratio0.720.752.852
Pretty Stable
Days Of Inventory Outstanding27.6131.0633.9022
Slightly volatile
Days Of Sales Outstanding68.1572.0574.0341
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9227
Slightly volatile
Fixed Asset Turnover0.02920.03075.3167
Slightly volatile
Debt Ratio0.02590.02720.3695
Slightly volatile
Price Sales Ratio7.617.255.4253
Slightly volatile
Asset Turnover0.00990.01050.1141
Slightly volatile

EnVVeno Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap970.3 K1.4 M1.1 M
Pretty Stable

EnVVeno Fundamental Market Drivers

EnVVeno Upcoming Events

25th of January 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
25th of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About EnVVeno Medical Financial Statements

EnVVeno Medical investors utilize fundamental indicators, such as revenue or net income, to predict how EnVVeno Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-491.1 K-466.5 K
Cost Of Revenue607.2 K478.3 K
Stock Based Compensation To Revenue 27.13  28.49 
Research And Ddevelopement To Revenue 63.55  66.73 
Capex To Revenue 10.48  11.01 
Revenue Per Share 69.77  66.28 
Ebit Per Revenue(282.51)(268.39)

Pair Trading with EnVVeno Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against EnVVeno Stock

  0.86GKOS Glaukos CorpPairCorr
  0.58BLCO Bausch Lomb CorpPairCorr
  0.41CYRX CryoportPairCorr
  0.37VPT VentriPoint DiagnosticsPairCorr
  0.36TMDX TransMedics GroupPairCorr
The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.
The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
Check out the analysis of EnVVeno Medical Correlation against competitors.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Will Health Care Equipment & Supplies sector continue expanding? Could EnVVeno diversify its offerings? Factors like these will boost the valuation of EnVVeno Medical. Anticipated expansion of EnVVeno directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every EnVVeno Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(37.80)
Return On Assets
(0.35)
Return On Equity
(0.57)
Understanding enVVeno Medical Corp requires distinguishing between market price and book value, where the latter reflects EnVVeno's accounting equity. The concept of intrinsic value—what EnVVeno Medical's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push EnVVeno Medical's price substantially above or below its fundamental value.
It's important to distinguish between EnVVeno Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EnVVeno Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, EnVVeno Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.